Roger Song
Stock Analyst at Jefferies
(3.47)
# 2,340
Out of 4,693 analysts
263
Total ratings
41.9%
Success rate
3.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Maintained: Buy | $2 → $24 | $15.67 | +53.16% | 16 | Aug 17, 2026 | |
| KLRA Kailera Therapeutics | Maintained: Buy | $48 | $16.41 | +192.50% | 4 | Aug 14, 2026 | |
| AVLN Avalyn Pharma | Maintained: Buy | $52 | $35.28 | +47.39% | 2 | Aug 13, 2026 | |
| INO Inovio Pharmaceuticals | Upgraded: Buy | $1.8 → $3 | $1.33 | +125.56% | 4 | Aug 12, 2026 | |
| ORKA Oruka Therapeutics | Maintained: Buy | $45 → $133 | $92.11 | +44.39% | 4 | Aug 11, 2026 | |
| BIOA BioAge Labs | Maintained: Buy | $62 → $21 | $9.52 | +120.59% | 7 | Jul 31, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $101 | $33.67 | +199.97% | 12 | Jul 30, 2026 | |
| MANE Veradermics | Maintained: Buy | $182 | $97.51 | +86.65% | 5 | Jul 16, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $83 | $56.09 | +47.98% | 6 | Jul 14, 2026 | |
| KRYS Krystal Biotech | Rated: Buy | $371 → $474 | $363.84 | +30.28% | 3 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $733 → $714 | $512.70 | +39.26% | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $26.04 | +72.81% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.70 | +197.30% | 1 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $2.43 | +64.61% | 1 | May 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $71 | $79.28 | -10.44% | 6 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.99 | +403.78% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $18 | $4.97 | +262.17% | 4 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.30 | +324.24% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $16 | $3.67 | +335.97% | 5 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $47.13 | +165.22% | 17 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $42 | $14.27 | +194.32% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $154 | $78.67 | +95.75% | 6 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $121 | $71.75 | +68.64% | 11 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $12.89 | +117.22% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $6.47 | +147.30% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $40 | $20.82 | +92.12% | 3 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.80 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $17 | $0.4765 | n/a | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $4 | $2.21 | n/a | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $60.93 | n/a | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $3.09 | n/a | 16 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $0.493 | n/a | 4 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $6.02 | n/a | 13 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 | $146.49 | n/a | 6 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.9447 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $146 | $60.81 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $18 | $2.07 | n/a | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $3.83 | n/a | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.000001 | n/a | 4 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $31.98 | n/a | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $25 | $10.12 | n/a | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $1.5 | $4.63 | n/a | 6 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $3 | $17.93 | n/a | 5 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $68 | $39.24 | n/a | 2 | Nov 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $5.49 | n/a | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $150.55 | n/a | 1 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $1.75 | n/a | 1 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $10.20 | n/a | 1 | Apr 13, 2021 |
Replimune Group
Aug 17, 2026
Maintained: Buy
Price Target: $2 → $24
Current: $15.67
Upside: +53.16%
Kailera Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $48
Current: $16.41
Upside: +192.50%
Avalyn Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $52
Current: $35.28
Upside: +47.39%
Inovio Pharmaceuticals
Aug 12, 2026
Upgraded: Buy
Price Target: $1.8 → $3
Current: $1.33
Upside: +125.56%
Oruka Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $45 → $133
Current: $92.11
Upside: +44.39%
BioAge Labs
Jul 31, 2026
Maintained: Buy
Price Target: $62 → $21
Current: $9.52
Upside: +120.59%
Viking Therapeutics
Jul 30, 2026
Maintained: Buy
Price Target: $101
Current: $33.67
Upside: +199.97%
Veradermics
Jul 16, 2026
Maintained: Buy
Price Target: $182
Current: $97.51
Upside: +86.65%
TG Therapeutics
Jul 14, 2026
Maintained: Buy
Price Target: $83
Current: $56.09
Upside: +47.98%
Krystal Biotech
Jul 13, 2026
Rated: Buy
Price Target: $371 → $474
Current: $363.84
Upside: +30.28%
Jul 10, 2026
Maintained: Buy
Price Target: $733 → $714
Current: $512.70
Upside: +39.26%
Jul 8, 2026
Maintained: Buy
Price Target: $45
Current: $26.04
Upside: +72.81%
May 20, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $3.70
Upside: +197.30%
May 19, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $2.43
Upside: +64.61%
Apr 28, 2026
Maintained: Buy
Price Target: $58 → $71
Current: $79.28
Upside: -10.44%
Apr 15, 2026
Maintained: Buy
Price Target: $10
Current: $1.99
Upside: +403.78%
Mar 26, 2026
Rated: Buy
Price Target: $26 → $18
Current: $4.97
Upside: +262.17%
Mar 23, 2026
Maintained: Buy
Price Target: $14
Current: $3.30
Upside: +324.24%
Mar 18, 2026
Reiterated: Buy
Price Target: $8 → $16
Current: $3.67
Upside: +335.97%
Feb 27, 2026
Maintained: Buy
Price Target: $125
Current: $47.13
Upside: +165.22%
Jan 22, 2026
Maintained: Buy
Price Target: $13 → $42
Current: $14.27
Upside: +194.32%
Dec 19, 2025
Maintained: Buy
Price Target: $154
Current: $78.67
Upside: +95.75%
Dec 17, 2025
Maintained: Buy
Price Target: $121
Current: $71.75
Upside: +68.64%
Dec 10, 2025
Maintained: Buy
Price Target: $28
Current: $12.89
Upside: +117.22%
Oct 10, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $6.47
Upside: +147.30%
Sep 9, 2025
Maintained: Buy
Price Target: $80 → $40
Current: $20.82
Upside: +92.12%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.80
Upside: n/a
Aug 22, 2025
Maintained: Buy
Price Target: $9 → $17
Current: $0.4765
Upside: n/a
Aug 20, 2025
Maintained: Buy
Price Target: $12 → $4
Current: $2.21
Upside: n/a
Aug 15, 2025
Initiated Coverage: Buy
Price Target: $36
Current: $60.93
Upside: n/a
Jun 26, 2025
Maintained: Buy
Price Target: $28
Current: $3.09
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $10 → $8
Current: $0.493
Upside: n/a
Apr 24, 2025
Maintained: Buy
Price Target: $7
Current: $6.02
Upside: n/a
Apr 10, 2025
Maintained: Buy
Price Target: $68
Current: $146.49
Upside: n/a
Apr 1, 2025
Initiated Coverage: Buy
Price Target: $6
Current: $0.9447
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $146
Current: $60.81
Upside: n/a
Mar 26, 2025
Rated: Buy
Price Target: $12 → $18
Current: $2.07
Upside: n/a
Mar 14, 2025
Initiated Coverage: Buy
Price Target: $7
Current: $3.83
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $8
Current: $0.000001
Upside: n/a
Jan 10, 2025
Rated: Buy
Price Target: $35
Current: $31.98
Upside: n/a
Oct 16, 2024
Maintained: Buy
Price Target: $31 → $25
Current: $10.12
Upside: n/a
Aug 21, 2024
Downgraded: Hold
Price Target: $14 → $1.5
Current: $4.63
Upside: n/a
Mar 27, 2024
Maintained: Buy
Price Target: $5 → $3
Current: $17.93
Upside: n/a
Nov 5, 2023
Rated: Buy
Price Target: $68
Current: $39.24
Upside: n/a
Jul 29, 2022
Initiated Coverage: Buy
Price Target: $9
Current: $5.49
Upside: n/a
May 18, 2021
Initiated Coverage: Buy
Price Target: $6
Current: $150.55
Upside: n/a
Apr 29, 2021
Maintained: Buy
Price Target: $23
Current: $1.75
Upside: n/a
Apr 13, 2021
Initiated Coverage: Buy
Price Target: $29
Current: $10.20
Upside: n/a